Paper39059178
Recent advances in MOF-based nanozymes: Synthesis, activities, and bioapplications.
Zhang Y and 7 others. Biosens Bioelectron, 2024. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Recent advances in MOF-based nanozymes: Synthesis, activities, and bioapplications. Papers, record 39059178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39059178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metal-Organic Frameworks | Major topic |
| Biosensing Techniques | Major topic |
| Nanostructures | Major topic |
| Humans | |
| Catalysis | |
| Nanotechnology | |
| Animals | |
| Neoplasms |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42825076 | Rare Earth-Silver Synergistic Strategy: Preparation of a Potential Antibacterial Material for Wound Related Applications. | ACS Omega | 2026 | https://conductscience.org/library/papers/42825076 | PubMed |
| 42720696 | Recent advances in MOF-phosphate interaction-based bioanalysis: from enrichment to sensing. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42720696 | PubMed |
| 42564780 | Zinc-MOF-carbon hollow sphere hybrid nanozyme for highly selective colorimetric detection of mercury ions. | RSC Adv | 2026 | https://conductscience.org/library/papers/42564780 | PubMed |
| 42521813 | Metal-organic frameworks for breath-based sensors: a review. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42521813 | PubMed |
| 42345898 | Nanozyme-Driven Multiplex Signal Lateral Flow Immunoassays for Chemical Contaminants in Food: A Review. | Biosensors (Basel) | 2026 | https://conductscience.org/library/papers/42345898 | PubMed |
| 42315652 | A novel 2D Co-MOF@MnO2 composite material with enhanced oxidase-like activity for rapid uric acid detection and portable sensor device development. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42315652 | PubMed |
| 42274672 | Cu-MOFs Nanozymes with Ascorbate Oxidase and Peroxidase-like Activity for Sensitive Fluorometric Detection of Total Antioxidant Capacity in Fruits. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/42274672 | PubMed |
| 42238958 | Recent advances in nanomaterial-based strategies for chronic pain alleviation. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42238958 | PubMed |
| 42149371 | Advances in Polydopamine-Based Nanoplatforms: Antioxidant Mechanisms and Applications in Oxidative Stress-Mediated Diseases. | Nanomicro Lett | 2026 | https://conductscience.org/library/papers/42149371 | PubMed |
| 42130833 | Design and optimization of a Cu-MOF@graphene oxide nanozyme for point-of-care colorimetric determination of sarcosine and H2O2. | RSC Adv | 2026 | https://conductscience.org/library/papers/42130833 | PubMed |
| 42125254 | Metal organic framework based synergistic improvement of hypoxia for optimizing diabetic wounds healing. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42125254 | PubMed |
| 42059320 | Hybrid Modification Strategies of Metal-Organic Frameworks: A Review on Structural Design and Environmental Applications. | ChemistryOpen | 2026 | https://conductscience.org/library/papers/42059320 | PubMed |
| 42033066 | A Needle-Like MOFzyme with High Aspect Ratio and Extended pH/Temperature Working Ranges for Total Antioxidant Capacity Determination and Oxidant-/Light-Free Dye Degradation. | ChemistryOpen | 2026 | https://conductscience.org/library/papers/42033066 | PubMed |
| 41945229 | Metal-Organic Framework Nanozymes: From Rational Design and Synthesis to Biomedical Applications. | Nanomicro Lett | 2026 | https://conductscience.org/library/papers/41945229 | PubMed |
| 41907370 | Therapeutic Nanozymes in Rheumatoid Arthritis Treatment Through Disease Stage-Oriented Strategies. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41907370 | PubMed |
| 41874749 | Colorimetric detection of amino acids enabled by functional nanomaterials: mechanisms, performance evaluation, and translational perspectives. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/41874749 | PubMed |
| 41660130 | Engineered targeted Ce-based MOF nanozymes for ROS scavenging and inflammatory Reprogramming in chronic pancreatitis. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41660130 | PubMed |
| 41310664 | Photocurable hydrogel containing MOF nanoenzymes for comprehensive pulpitis treatment: antibacterial, anti-inflammatory, and osteogenic actions. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41310664 | PubMed |
| 41227697 | Characterisation of SapYZUs891@Fe/Mn-MOF Provides Insight into the Selection of Temperate Phage and Nanozyme for the Rapid and Sensitive Colourimetric Detection of Viable Staphylococcus aureus in Food Products. | Foods | 2025 | https://conductscience.org/library/papers/41227697 | PubMed |
| 41194097 | A mitochondria-targeted nanomedicine for myocardial ischemia/reperfusion injury with synergistic antioxidant and anti-inflammatory properties. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41194097 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39059178
GET https://conductscience.org/api/papers/v1/39059178/cited_by?page=2